Stay updated on Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a minor update to the page. This update does not change any study details or user-facing content.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page now shows revision v3.6.2 as the current version, replacing the prior v3.6.0.SummaryDifference0.0%

- Check25 days agoChange DetectedThe Publications section loses a citation for Reck et al., Pembrolizumab vs Chemotherapy in PD-L1-positive NSCLC (KEYNOTE-024, NEJM 2016).SummaryDifference0.1%

- Check32 days agoChange DetectedRecruitment status is updated to indicate no longer seeking participants. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and implements minor formatting changes to the Intervention/Treatment header, along with a new revision tag (v3.6.0).SummaryDifference0.4%

- Check39 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, signaling a minor update to the page's version; no study details or primary content were changed.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4. This reflects a minor page update and does not alter the trial details, eligibility criteria, or results presented on the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page.